<SEC-DOCUMENT>0001157523-22-001263.txt : 20220926
<SEC-HEADER>0001157523-22-001263.hdr.sgml : 20220926
<ACCEPTANCE-DATETIME>20220926163015
ACCESSION NUMBER:		0001157523-22-001263
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220926
FILED AS OF DATE:		20220926
DATE AS OF CHANGE:		20220926

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		221266056

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a52922215.htm
<DESCRIPTION>ICON PLC 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 16pt; font-weight: bold;">&#160;FORM 6-K</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">For the month ended September, 2022</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 16pt; font-weight: bold;">ICON plc</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">(Registrant's name)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">333-08704</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">Brendan Brennan, CFO</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">South County Business Park, Leopardstown, Dublin 18, Ireland.</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">Brendan.Brennan@iconplc.com</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">00-353-1-291-2000</div>
    <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;(Name, telephone number, email and/or facsimile number and address of Company contact person)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfab5574f6cd64060b951fae7abfdec30">

        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Form 20-F __<font style="font-weight: bold;">X</font>___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Form 40-F ______</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under
              the Securities Exchange Act of 1934.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;">If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 <font style="font-weight: bold;">N/A</font></div>
          </td>
        </tr>

    </table>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;"><u>EXHIBIT LIST</u></div>
      <div style="font-family: 'Times New Roman', serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd6ab97c7a4b84e1b98f27af8a2d539f4">

          <tr>
            <td style="width: 13.1%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;"><u>Exhibit</u></div>
            </td>
            <td style="width: 86.84%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;"><u>Description</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.1%; vertical-align: middle;">
              <div style="font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
            <td style="width: 86.84%; vertical-align: middle;">
              <div style="font-family: 'Times New Roman', serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.1%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;"><a href="a52922215ex991.htm">99.1</a></div>
            </td>
            <td style="width: 86.84%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;"><a href="a52922215ex991.htm">ICON plc Schedules Third Quarter 2022 Earnings Conference Call</a></div>
            </td>
          </tr>

      </table>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">SIGNATURES</div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za14565c9ba774132a6a717f0462e3560">

            <tr>
              <td style="width: 55%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">ICON plc</div>
              </td>
            </tr>
            <tr>
              <td style="width: 55%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 55%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 55%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 55%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">/s/ Brendan Brennan</div>
              </td>
            </tr>
            <tr>
              <td style="width: 55%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Date: September 26, 2022</div>
              </td>
              <td style="width: 45%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman', serif;">Brendan Brennan</div>
                <div style="font-family: 'Times New Roman', serif;">Chief Financial Officer</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a52922215ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div><br>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>ICON plc Schedules Third Quarter 2022 Earnings Conference Call</b> </h1>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>DUBLIN--(BUSINESS WIRE)--September 26, 2022--ICON plc <b>(NASDAQ: ICLR),</b> a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the third quarter 2022
            after the market closes on Wednesday, November 2, 2022. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, November 3, 2022 at 8:00am ET. </p>
          <p> Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under &#8220;Events&#8221;. A webcast replay of the conference call will be available approximately one hour following the
            conclusion of the call. </p>
          <p> <b>About ICON plc</b> </p>
          <p> ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and
            public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 40,500 employees in 119 locations in 53 countries as at June
            30, 2022. For further information about ICON, visit: www.iconplc.com. </p>
          <p> This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
            guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
            and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
            offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
            to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
            The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
            publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
            ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov. </p>
          <p> Source: ICON plc </p>
          <p> <b>ICON/ICLR-G</b> </p>
        </div>
        <div class="bw-release-contact">
          <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
          <p> Kate Haven <br>
            Vice President Investor Relations <br>
            +1888 381 7923 </p>
        </div>
      </div>
    </div>
    <br>
    <font style="font-weight: bold;"></font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
